Frontiers in Diabetic Macular Edema: Durable Suppression for Addressing Health Disparities

Frontiers in Diabetic Macular Edema: Increasing Durability to Improve Vision Outcomes in Vulnerable Populations 

ReachMD Healthcare Image

How can we ensure that our most vulnerable patients with DME have the best chance for a good outcome? Learn how new agents are tackling this common problem. 

  • Overview

    New anti-angiogenic treatments are emerging that extend beyond current VEGF targets to reduce treatment burden and improve vision outcomes in DME. Explore how these new treatments work and examine the latest data around their use with our experts, Dr Christina Weng and Dr. Arshad Khanani.

Facebook Comments


We’re glad to see you’re enjoying Prova Education…
but how about a more personalized experience?

Register for free